ZA200700477B - 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri(hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors - Google Patents

1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri(hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors

Info

Publication number
ZA200700477B
ZA200700477B ZA200700477A ZA200700477A ZA200700477B ZA 200700477 B ZA200700477 B ZA 200700477B ZA 200700477 A ZA200700477 A ZA 200700477A ZA 200700477 A ZA200700477 A ZA 200700477A ZA 200700477 B ZA200700477 B ZA 200700477B
Authority
ZA
South Africa
Prior art keywords
hetero
heterocyclylethanes
arylethanes
tetra
tri
Prior art date
Application number
ZA200700477A
Inventor
Mark T Bilodeau
Wu Zhicai
Hartnett John
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA200700477B publication Critical patent/ZA200700477B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200700477A 2004-07-29 2007-01-16 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri(hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors ZA200700477B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59218104P 2004-07-29 2004-07-29

Publications (1)

Publication Number Publication Date
ZA200700477B true ZA200700477B (en) 2009-08-26

Family

ID=35613661

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200700477A ZA200700477B (en) 2004-07-29 2007-01-16 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri(hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors

Country Status (15)

Country Link
KR (1) KR20070043985A (en)
AR (1) AR049847A1 (en)
BR (1) BRPI0513793A (en)
CR (1) CR8876A (en)
EC (1) ECSP077208A (en)
IL (1) IL180846A0 (en)
MA (1) MA28980B1 (en)
MX (1) MX2007001188A (en)
NO (1) NO20071107L (en)
PE (1) PE20060382A1 (en)
RU (1) RU2344134C2 (en)
TW (1) TW200607493A (en)
UA (1) UA88018C2 (en)
WO (1) WO2006028590A1 (en)
ZA (1) ZA200700477B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120029447A1 (en) * 2009-03-18 2012-02-02 Medicure International Inc. Transdermal pharmaceutical preparation and administration of tirofiban
MY169219A (en) 2012-06-11 2019-03-19 Bristol Myers Squibb Co Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 ? sulfonamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE400551T1 (en) * 2002-01-04 2008-07-15 Neurosearch As POTASSIUM CHANNEL MODULATORS

Also Published As

Publication number Publication date
MX2007001188A (en) 2007-03-21
AR049847A1 (en) 2006-09-06
NO20071107L (en) 2007-04-19
BRPI0513793A (en) 2008-05-13
RU2007107408A (en) 2008-09-10
WO2006028590A1 (en) 2006-03-16
RU2344134C2 (en) 2009-01-20
MA28980B1 (en) 2007-11-01
KR20070043985A (en) 2007-04-26
UA88018C2 (en) 2009-09-10
CR8876A (en) 2007-08-28
PE20060382A1 (en) 2006-05-15
TW200607493A (en) 2006-03-01
ECSP077208A (en) 2007-02-28
IL180846A0 (en) 2007-06-03

Similar Documents

Publication Publication Date Title
ZA200407666B (en) Pyridinoylpiperidines as 5-HTif agonists.
HK1209729A1 (en) Compounds, compositions and methods
EP1781635A4 (en) Potassium channel inhibitors
ZA200610142B (en) Furanopyrimidine compounds effective as potassium channel inhibitors
AP2321A (en) Quinoline derivatives for use as mycobactrial inhibitor.
TWI369351B (en) 2,4-diamino-pyrimidines as aurora inhibitors
AP2280A (en) Compositions and methods for increasing telomeraseactivity.
ZA200502210B (en) Substrates for O6-alkylguanine-DNA alkyltansferase.
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
HK1102583A1 (en) Sulphonylpyrroles as hdac inhibitors
ZA200705040B (en) 2,4 (4,6) pyrimidine derivatives
EP1667683A4 (en) Quinoline potassium channel inhibitors
WO2006009649A3 (en) Brassica indehiscent1 sequences
EP1940406A4 (en) Potassium channel inhibitors
WO2007062308A3 (en) Homo- and heterocyclic compounds suitable as cetp inhibitors
EP1493437A4 (en) Compositions for diabetes
ZA200307420B (en) Point chisel.
ZA200805028B (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
HK1115878A1 (en) (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
AU2003212310A1 (en) (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
EP1776355A4 (en) Potassium channel inhibitors
ZA201005087B (en) 4-imidazolidinones as kv1.5 potassium channel inhibitors
EP1667973A4 (en) Quinoline potassium channel inhibitors
EP1723145A4 (en) Substituted 5,12-diaza-benzoanthracene analogues
IL180846A0 (en) 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors